JP2023512631A5 - - Google Patents
Info
- Publication number
- JP2023512631A5 JP2023512631A5 JP2022543767A JP2022543767A JP2023512631A5 JP 2023512631 A5 JP2023512631 A5 JP 2023512631A5 JP 2022543767 A JP2022543767 A JP 2022543767A JP 2022543767 A JP2022543767 A JP 2022543767A JP 2023512631 A5 JP2023512631 A5 JP 2023512631A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- tcrs
- sequence
- cdr3b
- cdr3a
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2020/051439 WO2021148110A1 (en) | 2020-01-21 | 2020-01-21 | Hbv specific tcr library and its use as personalised medicine |
| EPPCT/EP2020/051439 | 2020-01-21 | ||
| PCT/EP2021/051356 WO2021148547A1 (en) | 2020-01-21 | 2021-01-21 | Hbv specific tcr library and its use as personalised medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512631A JP2023512631A (ja) | 2023-03-28 |
| JP2023512631A5 true JP2023512631A5 (https=) | 2024-01-24 |
Family
ID=69187789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022543767A Pending JP2023512631A (ja) | 2020-01-21 | 2021-01-21 | Ｈｂｖ特異的ｔｃｒライブラリーおよび個別化医療としてのその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230061817A1 (https=) |
| EP (1) | EP4093759A1 (https=) |
| JP (1) | JP2023512631A (https=) |
| KR (1) | KR20220148809A (https=) |
| CN (1) | CN115335397A (https=) |
| TW (1) | TW202140534A (https=) |
| WO (2) | WO2021148110A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110156889B (zh) * | 2018-02-14 | 2023-03-10 | 中国科学院广州生物医药与健康研究院 | 高亲和力HBs T细胞受体 |
| US20250273289A1 (en) * | 2024-02-23 | 2025-08-28 | Tata Consultancy Services Limited | Insilico method and system for designing a baseline peptide bioreceptor for sensing a biomarker for dysglycemic disorders |
| CN121319150B (zh) * | 2025-12-16 | 2026-04-14 | 温州医科大学 | 一种同时识别hbv核心抗原表位及包膜蛋白表位的tcr及其编码序列 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8603810B2 (en) * | 2008-05-09 | 2013-12-10 | Agency For Science, Technology And Research | T-cell having a T-cell receptor that recognizes epitope HBC18-27 of hepatitis B viral core antigen |
| DK3399985T3 (da) * | 2016-01-06 | 2022-03-21 | Health Research Inc | Sammensætninger og biblioteker, der omfatter rekombinante T-cellereceptorer, og fremgangsmåder til anvendelse af rekombinante T-cellereceptorer |
| KR20190006952A (ko) | 2016-03-31 | 2019-01-21 | 라이언 티씨알 피티이. 리미티드 | 외인성 바이러스-특이적 t 세포 수용체 (tcr)를 발현하는 비-활성화된 t 세포 |
| SG11201901634UA (en) * | 2016-09-23 | 2019-04-29 | Lion Tcr Pte Ltd | An hbv antigen specific binding molecules and fragments thereof |
-
2020
- 2020-01-21 WO PCT/EP2020/051439 patent/WO2021148110A1/en not_active Ceased
-
2021
- 2021-01-21 JP JP2022543767A patent/JP2023512631A/ja active Pending
- 2021-01-21 WO PCT/EP2021/051356 patent/WO2021148547A1/en not_active Ceased
- 2021-01-21 TW TW110102357A patent/TW202140534A/zh unknown
- 2021-01-21 KR KR1020227028454A patent/KR20220148809A/ko active Pending
- 2021-01-21 EP EP21702405.8A patent/EP4093759A1/en not_active Withdrawn
- 2021-01-21 CN CN202180020544.2A patent/CN115335397A/zh active Pending
- 2021-01-21 US US17/794,379 patent/US20230061817A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021202223B2 (en) | Methods of isolating T cells having antigenic specificity for a cancer-specific mutation | |
| AU2021200388B2 (en) | Methods of isolating T cell receptors having antigenic specificity for a cancer specific mutation | |
| EP2288700B1 (en) | Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof | |
| JP2018183175A (ja) | Ｗｔ−１に特異的なｔ細胞免疫治療 | |
| JP2023512631A5 (https=) | ||
| JP6580579B2 (ja) | Ｔ細胞受容体を発現する細胞を生産する方法および組成物 | |
| RU2680588C2 (ru) | Гены рецепторов антигенспецифичных хелперных т-клеток | |
| TW202140534A (zh) | 個人化醫藥 | |
| CN113150111A (zh) | 一种HLA-A*0201限制性CMVpp65特异性T细胞受体及其应用 | |
| AU2018250926B2 (en) | Methods to produce peptides, polypeptides or cells for modulating immunity | |
| WO2023142683A1 (zh) | 靶向巨细胞病毒抗原的tcr和表达其的t细胞及应用 | |
| CN114249811A (zh) | 一种特异识别癌/睾丸抗原hca587/magec2的t细胞受体及其应用 | |
| BR112016015736B1 (pt) | Uso de um aloantígeno, uma molécula que interage com receptor de superfície cd40 e citocinas tipo i; e pelo menos um ou mais antígenos de hiv, kit, composição e composição de avi | |
| CN119923271A (zh) | 包含结核病抗原的疫苗构建体 | |
| AU2023282185B2 (en) | Methods of isolating T cell receptors having antigenic specificity for a cancer specific mutation | |
| AU2023285735B2 (en) | Methods of isolating T cells having antigenic specificity for a cancer-specific mutation | |
| EP3990003A1 (en) | Cd5 specific t cell receptor cell or gene therapy | |
| RU2809113C2 (ru) | Универсальные антигенпрезентирующие клетки и их применения | |
| WO2024243807A1 (zh) | 靶向ny-eso-1的高亲和力t细胞受体及其应用 | |
| WO2024222701A1 (zh) | 一种t细胞受体及其用途 | |
| KR20230066419A (ko) | 장기 이식 환자의 면역-요법을 위한 면역억제제 약물 저항성 무장 tcr t 세포 | |
| Agrawal et al. | HETEROLOGOUS IMMUNITY: IMPLICATIONS AND APPLICATIONS IN VACCINES AND IMMUNOTHERAPIES |